- Home
- GCV vs ZYXI Comparison
GCV vs ZYXI Comparison
Compare GCV & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- ZYXI
- Stock Information
- Founded
- GCV 1988
- ZYXI 1996
- Country
- GCV United States
- ZYXI United States
- Employees
- GCV N/A
- ZYXI N/A
- Industry
- GCV Finance/Investors Services
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GCV Finance
- ZYXI Health Care
- Exchange
- GCV Nasdaq
- ZYXI Nasdaq
- Market Cap
- GCV 75.6M
- ZYXI 66.5M
- IPO Year
- GCV N/A
- ZYXI N/A
- Fundamental
- Price
- GCV $3.36
- ZYXI $2.18
- Analyst Decision
- GCV
- ZYXI Buy
- Analyst Count
- GCV 0
- ZYXI 3
- Target Price
- GCV N/A
- ZYXI $10.25
- AVG Volume (30 Days)
- GCV 57.9K
- ZYXI 262.3K
- Earning Date
- GCV 01-01-0001
- ZYXI 04-29-2025
- Dividend Yield
- GCV 13.04%
- ZYXI N/A
- EPS Growth
- GCV N/A
- ZYXI N/A
- EPS
- GCV N/A
- ZYXI 0.09
- Revenue
- GCV N/A
- ZYXI $192,354,000.00
- Revenue This Year
- GCV N/A
- ZYXI N/A
- Revenue Next Year
- GCV N/A
- ZYXI $23.16
- P/E Ratio
- GCV N/A
- ZYXI $24.22
- Revenue Growth
- GCV N/A
- ZYXI 4.36
- 52 Week Low
- GCV $3.15
- ZYXI $1.93
- 52 Week High
- GCV $4.58
- ZYXI $12.19
- Technical
- Relative Strength Index (RSI)
- GCV 34.90
- ZYXI 26.14
- Support Level
- GCV $3.35
- ZYXI $2.03
- Resistance Level
- GCV $3.59
- ZYXI $2.24
- Average True Range (ATR)
- GCV 0.16
- ZYXI 0.18
- MACD
- GCV -0.02
- ZYXI 0.17
- Stochastic Oscillator
- GCV 46.05
- ZYXI 38.46
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.